488 related articles for article (PubMed ID: 19580818)
1. Chronic morphine treatment induces functional delta-opioid receptors in amygdala neurons that project to periaqueductal grey.
Chieng B; Christie MJ
Neuropharmacology; 2009 Sep; 57(4):430-7. PubMed ID: 19580818
[TBL] [Abstract][Full Text] [Related]
2. Effect of the {mu} opioid on excitatory and inhibitory synaptic inputs to periaqueductal gray-projecting neurons in the amygdala.
Finnegan TF; Chen SR; Pan HL
J Pharmacol Exp Ther; 2005 Feb; 312(2):441-8. PubMed ID: 15388784
[TBL] [Abstract][Full Text] [Related]
3. Characterization of neurons in the rat central nucleus of the amygdala: cellular physiology, morphology, and opioid sensitivity.
Chieng BC; Christie MJ; Osborne PB
J Comp Neurol; 2006 Aug; 497(6):910-27. PubMed ID: 16802333
[TBL] [Abstract][Full Text] [Related]
4. GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine.
Cabral A; Ruggiero RN; Nobre MJ; Brandão ML; Castilho VM
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):334-44. PubMed ID: 19150477
[TBL] [Abstract][Full Text] [Related]
5. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
[TBL] [Abstract][Full Text] [Related]
6. Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphine.
Bagley EE; Chieng BC; Christie MJ; Connor M
Br J Pharmacol; 2005 Sep; 146(1):68-76. PubMed ID: 15980868
[TBL] [Abstract][Full Text] [Related]
7. Morphine alters the selective association between mu-opioid receptors and specific RGS proteins in mouse periaqueductal gray matter.
Garzón J; Rodríguez-Muñoz M; Sánchez-Blázquez P
Neuropharmacology; 2005 May; 48(6):853-68. PubMed ID: 15829256
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin and nociceptin inhibit neurons in the central nucleus of amygdala that project to the periaqueductal grey.
Chieng B; Christie MJ
Neuropharmacology; 2010 Nov; 59(6):425-30. PubMed ID: 20541564
[TBL] [Abstract][Full Text] [Related]
9. Increased level of neuronal phosphoinositide 3-kinase gamma by the activation of mu-opioid receptor in the mouse periaqueductal gray matter: further evidence for the implication in morphine-induced antinociception.
Narita M; Imai S; Narita M; Kasukawa A; Yajima Y; Suzuki T
Neuroscience; 2004; 124(3):515-21. PubMed ID: 14980723
[TBL] [Abstract][Full Text] [Related]
10. Antinociception following application of DAMGO to the basolateral amygdala results from a direct interaction of DAMGO with Mu opioid receptors in the amygdala.
Shin MS; Helmstetter FJ
Brain Res; 2005 Dec; 1064(1-2):56-65. PubMed ID: 16289487
[TBL] [Abstract][Full Text] [Related]
11. Postsynaptic actions of substance P on rat periaqueductal grey neurons in vitro.
Drew GM; Mitchell VA; Vaughan CW
Neuropharmacology; 2005 Oct; 49(5):587-95. PubMed ID: 15921708
[TBL] [Abstract][Full Text] [Related]
12. Evidence for an intrinsic mechanism of antinociceptive tolerance within the ventrolateral periaqueductal gray of rats.
Lane DA; Patel PA; Morgan MM
Neuroscience; 2005; 135(1):227-34. PubMed ID: 16084660
[TBL] [Abstract][Full Text] [Related]
13. Antinociception produced by mu opioid receptor activation in the amygdala is partly dependent on activation of mu opioid and neurotensin receptors in the ventral periaqueductal gray.
Tershner SA; Helmstetter FJ
Brain Res; 2000 May; 865(1):17-26. PubMed ID: 10814729
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive effect of calcitonin gene-related peptide in the central nucleus of amygdala: activating opioid receptors through amygdala-periaqueductal gray pathway.
Xu W; Lundeberg T; Wang YT; Li Y; Yu LC
Neuroscience; 2003; 118(4):1015-22. PubMed ID: 12732246
[TBL] [Abstract][Full Text] [Related]
15. Effect of morphine on deep dorsal horn projection neurons depends on spinal GABAergic and glycinergic tone: implications for reduced opioid effect in neuropathic pain.
Chen YP; Chen SR; Pan HL
J Pharmacol Exp Ther; 2005 Nov; 315(2):696-703. PubMed ID: 16033910
[TBL] [Abstract][Full Text] [Related]
16. Effects of electrolytic lesion of dorsolateral periaqueductal gray on analgesic response of morphine microinjected into the nucleus cuneiformis in rat.
Haghparast A; Ahmad-Molaei L
Neurosci Lett; 2009 Feb; 451(2):165-9. PubMed ID: 19146915
[TBL] [Abstract][Full Text] [Related]
17. Relationship of mu- and delta-opioid receptors to GABAergic neurons in the central nervous system, including antinociceptive brainstem circuits.
Kalyuzhny AE; Wessendorf MW
J Comp Neurol; 1998 Mar; 392(4):528-47. PubMed ID: 9514515
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of opioid inhibition of GABAergic synaptic transmission by cyclo-oxygenase inhibitors in rat periaqueductal grey neurones.
Vaughan CW
Br J Pharmacol; 1998 Apr; 123(8):1479-81. PubMed ID: 9605550
[TBL] [Abstract][Full Text] [Related]
19. Mu-opioid receptor activation induces transcriptional plasticity in the central extended amygdala.
Befort K; Filliol D; Ghate A; Darcq E; Matifas A; Muller J; Lardenois A; Thibault C; Dembele D; Le Merrer J; Becker JA; Poch O; Kieffer BL
Eur J Neurosci; 2008 Jun; 27(11):2973-84. PubMed ID: 18588537
[TBL] [Abstract][Full Text] [Related]
20. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores.
Lenard NR; Daniels DJ; Portoghese PS; Roerig SC
Eur J Pharmacol; 2007 Jul; 566(1-3):75-82. PubMed ID: 17383633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
